Showing 281 - 300 results of 1,132 for search '"immunosuppression"', query time: 0.04s Refine Results
  1. 281

    Microscopic Polyangiitis with Pulmonary Fibrosis: An Often-Recognized Manifestation of the Disease by Liam M. Clifford, Jamma Li, Christopher J. Renaud, Suran L. Fernando

    Published 2019-01-01
    “…Both patients responded well to immunosuppressive treatment; however, pulmonary fibrosis and COPD were refractory to immunosuppression. …”
    Get full text
    Article
  2. 282

    Control of Cross Talk between Angiogenesis and Inflammation by Mesenchymal Stem Cells for the Treatment of Ocular Surface Diseases by Fei Li, Shao-zhen Zhao

    Published 2016-01-01
    “…Although great progress has been achieved, healing of severe ocular surface injury and immunosuppression of corneal transplantation are the most difficult and challenging step in the treatment of ocular surface disorders. …”
    Get full text
    Article
  3. 283
  4. 284

    A Rare Sequela of Acute Disseminated Encephalomyelitis by Vijay Kodadhala, Saravana Devulapalli, Mohankumar Kurukumbi, Annapurni Jayam-Trouth

    Published 2014-01-01
    “…Our case is unique, as acute disseminated encephalomyelitis occurred in a 34-year-old which was poorly responsive to immunosuppression resulting in severe disability.…”
    Get full text
    Article
  5. 285

    The Conundrum of Septic Shock Imitators in Patients with Hematologic Cancers: Case Presentation and Possible Differential Diagnoses by Giorgio Berlot, Giulia Moratelli, Martina Tarchini, Katiuscia Battaglia, Paolo Grassi, Nadia Zarrillo, Vincenzo Colella, Rossana Bussani

    Published 2019-01-01
    “…In this article, the mimickers of septic shock are reviewed and discussed, as some of them require an aggressive immunosuppression instead of the recommended treatment for septic shock.…”
    Get full text
    Article
  6. 286

    Chronic Lymphocytic Inflammation with Pontine Perivascular Enhancement Responsive to Steroids, with Cranial and Caudal Extension by Mahmood Mubasher, Aseel Sukik, Ahmed Hassan El Beltagi, Ali Rahil

    Published 2017-01-01
    “…Our report addresses the radiological and clinical pattern of a case of CLIPPERS rhombencephalitis, with added superior and inferior extension to involve the brain and spinal cord, which is to emphasize the importance of raising the awareness of this disease and the combined role of radiologist and physicians for the diagnosis of this potentially treatable entity, responsive to glucocorticosteroid immunosuppression.…”
    Get full text
    Article
  7. 287

    Improving the Safety of Tolerance Induction: Chimerism and Cellular Co-Treatment Strategies Applied to Vascularized Composite Allografts by Wei-Chao Huang, Jeng-Yee Lin, Christopher Glenn Wallace, Fu-Chan Wei, Shuen-Kuei Liao

    Published 2012-01-01
    “…Although vascularized composite allografts (VCAs) have been performed clinically for a variety of indications, potential complications from long-term immunosuppression and graft-versus-host disease remain important barriers to widespread applications. …”
    Get full text
    Article
  8. 288

    Autoimmune Hepatitis—Immunologically Triggered Liver Pathogenesis—Diagnostic and Therapeutic Strategies by Elisabeth Sucher, Robert Sucher, Tanja Gradistanac, Gerald Brandacher, Stefan Schneeberger, Thomas Berg

    Published 2019-01-01
    “…AIH responds favorably to steroids and pharmacologic immunosuppression, and liver transplantation is only necessary in cases with acute liver failure or end-stage liver cirrhosis. …”
    Get full text
    Article
  9. 289

    The Dendritic Cell-Regulatory T Lymphocyte Crosstalk Contributes to Tumor-Induced Tolerance by Nona Janikashvili, Bernard Bonnotte, Emmanuel Katsanis, Nicolas Larmonier

    Published 2011-01-01
    “…Regulatory T lymphocytes (Treg) and tolerogenic dendritic cells play essential roles in the establishment and persistence of cancer-induced immunosuppression. Differentiating dendritic cells (DCs) exposed to tumor-derived factors may be arrested at an immature stage becoming inept at initiating immune responses and may induce effector T-cell anergy or deletion. …”
    Get full text
    Article
  10. 290

    A Rare Occurrence of Primary Hepatic Leiomyosarcoma Associated with Epstein Barr Virus Infection in an AIDs Patient by Haritha Chelimilla, Kanthi Badipatla, Ariyo Ihimoyan, Masooma Niazi

    Published 2013-01-01
    “…Close association of Epstein Barr virus (EBV) induced soft tissue sarcomas is proven, especially in the presence of immunosuppression encountered in HIV/AIDS patients and in posttransplant patients. …”
    Get full text
    Article
  11. 291

    NF-κB signaling and the tumor microenvironment in osteosarcoma: implications for immune evasion and therapeutic resistance by Shaoyan Shi, Xuehai Ou, Chao Liu, Rui Li, Qianjin Zheng, Leiming Hu

    Published 2025-01-01
    “…This research aimed to explore how NF-κB influences the recruitment and polarization of tumor-associated macrophages and myeloid-derived suppressor cells, both of which contribute to immunosuppression. Furthermore, NF-κB facilitates immune surveillance evasion in osteosarcoma cells by altering the expression of immune checkpoint molecules, such as PD-L1. …”
    Get full text
    Article
  12. 292

    Vertebral Artery Thrombosis in Chronic Idiopathic Thrombocytopenic Purpura by Zakaria Hindi, Nirmal Onteddu, Christopher A. Ching, Abdallah A. Khaled

    Published 2017-01-01
    “…While usage of antiplatelet therapy in such patients is debated, immunosuppression therapy has been the mainstay treatment in all published cases.…”
    Get full text
    Article
  13. 293

    Oxford-AstraZeneca Coronavirus Disease-2019 Vaccine-Induced Immune Thrombocytopenia on Day Two by Azhar Kareem Razzaq, Ameer Al-Jasim

    Published 2021-01-01
    “…ITP is treated with immunosuppression. Case Presentation. A 26-year-old Iraqi male laboratory analyst with an unremarkable medical history presented with severe thrombocytopenia 2 days after receiving the Oxford-AstraZeneca coronavirus disease-2019 vaccine. …”
    Get full text
    Article
  14. 294

    ACSL4 promotes the formation of the proliferative subtype in hepatoblastoma by Wei Dang, Qin Li, Xiaoying Wang

    Published 2025-02-01
    “…Among them, the proliferative subtype, characterized by enhanced proliferative capacity, poor prognosis, and an immunosuppressive tumor microenvironment, was particularly notable. …”
    Get full text
    Article
  15. 295

    Pancreatitis in systemic lupus erythematosus: Clinical characterization and outcome analysis in concurrent pancreatitis and lupus by Sheba Charles, Benzeeta Pinto, Vineeta Shobha

    Published 2021-01-01
    “…All our patients were treated with high-dose steroids and other immunosuppression as indicated for concomitant disease activity. …”
    Get full text
    Article
  16. 296

    Potential Application of Tregitopes as Immunomodulating Agents in Multiple Sclerosis by Wassim Elyaman, Samia J. Khoury, David W. Scott, Anne S. De Groot

    Published 2011-01-01
    “…Tregitopes expand Treg cells and induce “adaptive Tregs” resulting in immunosuppression and, therefore, are being considered as a potential therapy for autoimmune diseases. …”
    Get full text
    Article
  17. 297

    Ocular manifestations of COVID-19 by Sandra Saray Quignón Santana, Osbel Alfonso Sánchez, Sandra Alfonso Quignón, Talía Alfonso Quignón

    Published 2022-12-01
    “…In the recovery stage, ocular findings associated with systemic immunosuppression, vasculitic and thromboembolic processes are presented. …”
    Get full text
    Article
  18. 298

    Listeria Rhombencephalitis Complicating Anti-TNF Treatment during an Acute Flare of Crohn’s Colitis by L. Stratton, G. R. Caddy

    Published 2016-01-01
    “…Patients with Crohn’s disease often require the use of immunosuppressant drugs to control disease activity. Such medication includes steroids, azathioprine, and biologic therapy. …”
    Get full text
    Article
  19. 299

    Granulocytic Sarcoma by AML M4eo (inv16) after Allogeneic Stem Cell Transplantation without Bone Marrow Involvement by Stephan Zaenker, Stefan Schweyer, Justin Hasenkamp, Lorenz Truemper, Gerald Wulf

    Published 2011-01-01
    “…The patient underwent the withdrawal of immunosuppression, hysterectomy, and local irradiation at first relapse, as well as systemic chemotherapy and donor lymphocyte infusions at second recurrence, inducing a second and third complete remission, respectively. …”
    Get full text
    Article
  20. 300

    Vascular cytoprotection, autoimmune disease, and premature atherosclerosis by Justin C Mason

    Published 2018-01-01
    “…Identification of safe therapeutic approaches that combine the targeted immunosuppression required, along with comprehensive vascular protection to control the primary disease and prevent secondary complications over the longer term, remains the ultimate challenge.…”
    Get full text
    Article